Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VetoquinolLTS:0O1O -1.09%80 Days Inventory is 1,498.10 as of Dec. 2025, which is 534% above its 10-year median of 236.21. GuruFocus rates LTS:0O1O with a GF Score™ of 80/100 and a GF Value™ of €85.90 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 923 Drug Manufacturers companies, Vetoquinol ranks worse than 87.97% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vetoquinol's Average Total Inventories for the
six
months ended in Dec. 2025 was €126.5 Mil. Vetoquinol's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €15.4 Mil.
Hence, Vetoquinol's Days Inventory for the
six
months ended in Dec. 2025 was 1,498.10.
The historical rank and industry rank for Vetoquinol's Days Inventory or its related term are showing as below:
LTS:0O1O'
s Days Inventory Range Over the Past 10 Years
Min: 213.88 Med: 236.21 Max: 334.48
Current: 334.48
During the past 13 years, Vetoquinol's highest Days Inventory was 334.48. The lowest was 213.88. And the median was 236.21.
LTS:0O1O's Days Inventory is ranked worse than 87.97% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs LTS:0O1O: 334.48
Vetoquinol's Days Inventory
increased
from Dec. 2024 (1,142.85) to Dec. 2025 (1,498.10).
It might indicate that Vetoquinol's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vetoquinol's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vetoquinol's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.47.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vetoquinol's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vetoquinol's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vetoquinol Days Inventory Related Terms
Vetoquinol Days Inventory Historical Data
* Premium members only.
The historical data trend for Vetoquinol's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0O1O vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vetoquinol's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vetoquinol Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vetoquinol's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vetoquinol's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetoquinol (LTS:0O1O) has a Days Inventory of 1,498.10 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vetoquinol and its competitors. This is 534% above median its historical median of 236.21. Over the past decade, Vetoquinol's Days Inventory has ranged from 213.88 to 334.48. According to the industry distribution chart, Vetoquinol ranks #812 out of 923 companies in the Drug Manufacturers industry, placing it in the top 88%.
Is Vetoquinol's Days Inventory too high?
Vetoquinol's current Days Inventory of 1,498.10 is 534% above median its 10-year median of 236.21. Over the past 10 years, this metric has ranged from a low of 213.88 to a high of 334.48. The Drug Manufacturers industry median Days Inventory is 164.87. Vetoquinol's value of 1,498.10 is 808.7% above this industry median. Based on the distribution chart, Vetoquinol ranks #812 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vetoquinol has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetoquinol's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vetoquinol ranks #812 out of 923 companies for Days Inventory. This places Vetoquinol in the lower half of its industry. The industry median Days Inventory is 164.87. Vetoquinol's value of 1,498.10 is 808.7% above this benchmark. Historically, Vetoquinol's own Days Inventory has ranged from 213.88 to 334.48 over the past decade. While the company's 10-year median is 236.21 vs. the industry median of 164.87, Vetoquinol has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetoquinol's current Days Inventory of 1,498.10 is 808.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vetoquinol and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetoquinol's current Days Inventory is 1,498.10, which is 534% above median its own 10-year median of 236.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetoquinol stock overvalued right now?
Based on GuruFocus' analysis, Vetoquinol (LTS:0O1O) is currently considered Modestly Undervalued. The stock's GF Value™ is €85.90, compared to a current price of €72.30 — trading 15.8% below its estimated fair value. The current Days Inventory is 1,498.10, which is 534% above median its 10-year median of 236.21 and 808.7% above the Drug Manufacturers industry median of 164.87. Vetoquinol's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vetoquinol (LTS:0O1O), the current Days Inventory is 1,498.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vetoquinol (LTS:0O1O) Overvalued in 2026?
Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued.
The current stock price of €72.30 is trading 15.8% below its estimated GF Value™ of €85.90.
GuruFocus considers Vetoquinol to be Modestly Undervalued.
Key valuation signals for LTS:0O1O:
Days Inventory: 1,498.10 (534% above median its 10-year median of 236.21)
GF Value™: €85.90 vs. price of €72.30 (15.8% below fair value)
Industry Position: 808.7% above the Drug Manufacturers median (#812 of 923)
No single metric tells the full story. See the LTS:0O1O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
80GF Score
Get the complete analysis for LTS:0O1O
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0O1O has been successfully added to your 
